More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
MJNA Revenue Growth and Investment Opportunities Take Center Stage on Open Source Site Minds.com

MJNA Revenue Growth and Investment Opportunities Take Center Stage on Open Source Site Minds.com

by adminAdrianRamirez | Oct 26, 2017 | Media Coverage

Medical Marijuana, Inc. and its portfolio of companies were recently showcased on the open-source, community-owned social networking service, Minds.com. For Medical Marijuana, Inc. (MJNA), the second quarter of 2017 generated the largest revenue quarter in the...
Medical Marijuana, Inc. Announces CEO Dr. Stuart Titus as Speaker at Autism Tree Project Foundation 3rd Annual Neuroscience Conference

Medical Marijuana, Inc. Announces CEO Dr. Stuart Titus as Speaker at Autism Tree Project Foundation 3rd Annual Neuroscience Conference

by adminAdrianRamirez | Oct 25, 2017 | Press Releases

SAN DIEGO, Oct. 25, 2017 — Medical Marijuana, Inc.(OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that CEO Dr. Stuart Titus will be speaking on the CBD oil panel at the Autism Tree Project Foundation 3rd Annual...
Medical Marijuana, Inc. Subsidiary HempMeds® Brazil Announces Prominent Coverage in Brazilian Newspapers After Legal Victory

Medical Marijuana, Inc. Subsidiary HempMeds® Brazil Announces Prominent Coverage in Brazilian Newspapers After Legal Victory

by adminAdrianRamirez | Oct 25, 2017 | HempMeds Brasil, Press Releases

Federal Judge in Brazil Orders the Government to Subsidize Payments for Real Scientific Hemp Oil™ (RSHO™) for Brazilian Citizen SAN DIEGO, Oct. 24, 2017 — Medical Marijuana, Inc.(OTC:MJNA), the first-ever publicly traded cannabis company in the United States,...
MJNA Mentioned in The Motley Fool’s Guide on MMJ Investing

MJNA Mentioned in The Motley Fool’s Guide on MMJ Investing

by adminAdrianRamirez | Oct 24, 2017 | Media Coverage

Medical Marijuana, Inc. is highlighted in the investor advising website’s short guide on investing in marijuana stocks. The Motley Fool highlighted Medical Marijuana, Inc. (OTC: MJNA) in a new article this week on how to invest and profit in the cannabis industry. The...
Medical Marijuana Inc. Referenced in Milenio, One of Mexico’s Largest Daily Newspapers

Medical Marijuana Inc. Referenced in Milenio, One of Mexico’s Largest Daily Newspapers

by adminAdrianRamirez | Oct 20, 2017 | Media Coverage

Article on doctors’ concerns about Mexico’s recent approval of medical cannabis highlighted Medical Marijuana Inc.’s estimate on the size of the nation’s MMJ market Mexico legalized medical cannabis in the first half of 2017 after extensive public debate over the...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.